Heart & Kidney interactions: What are the challenges for prevention and protection?

10' education - Sep. 2, 2019 - Prof. Christoph Wanner - Würzburg, Germany

Video navigation menu

Facts about and challenges in cardio-renal syndrome 1:49
Renal function in patients with HF 3:29
Effect of empagliflozin in cardiorenal patients 4:12
Where to go from here? 8:32
Recommendations on treatment 10:31

Educational information

This lecture held by prof. Wanner was part of an accredited symposium "Expanding opportunities for SGLT2i in clinical cardiology" held during ESC Congress 2019 in Paris, France.

Faculty

Prof. Christoph Wanner, Division of Nephrology and Hypertension at the University Hospital of Würzburg, Germany

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim/Lilly.

View the slides of this presentation Go to the meeting report of this symposium

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.